Compare RGCO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGCO | EMBC |
|---|---|---|
| Founded | 1912 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.5M | 199.9M |
| IPO Year | 2005 | 2021 |
| Metric | RGCO | EMBC |
|---|---|---|
| Price | $21.94 | $3.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $22.70 | $18.50 |
| AVG Volume (30 Days) | 12.2K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | 3.93% | ★ 6.88% |
| EPS Growth | 11.21 | ★ 20.90 |
| EPS | ★ 1.31 | 0.67 |
| Revenue | ★ $95,334,212.00 | N/A |
| Revenue This Year | $11.06 | $1.17 |
| Revenue Next Year | $2.89 | N/A |
| P/E Ratio | $16.56 | ★ $5.33 |
| Revenue Growth | ★ 12.63 | N/A |
| 52 Week Low | $20.55 | $2.77 |
| 52 Week High | $27.17 | $15.55 |
| Indicator | RGCO | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.